Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx.

COVID-19 Oxford Nanopore Technology SARS-CoV-2 nasopharyngeal swab ocular swab ocular transmission virus culture whole genome sequencing

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 02 11 2023
accepted: 05 02 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

SARS-CoV-2 is known to infect respiratory tissue cells. However, less is known about infection of ocular tissue and potential infectivity of lacrimal fluid. With this study, we want to compare viral loads in eye and nasopharyngeal swabs and analyze these for infectious virus. Between May 2020 and April 2021 ocular and nasopharyngeal swabs were collected from 28 SARS-CoV-2 infected patients treated on the corona virus disease 2019 (COVID-19)-ward of the University Hospital of Innsbruck, Austria. Samples with PCR detectable SARS-CoV-2 were analyzed via whole genome sequencing and an attempt was made to isolate infectious virus. At the time point of sample collection, 22 individuals were still PCR positive in nasopharyngeal samples and in 6 of these patients one or both ocular samples were additionally positive. CT-values in eyes were generally higher compared to corresponding nasopharyngeal samples and we observed a tendency for lower CT-values, i.e. increased viral load, in nasopharyngeal swabs of individuals with at least one infected eye, compared to those where ocular samples were PCR negative. Ocular and nasopharyngeal sequences from the same patient were assigned to the same variant, either the D614G or the Alpha variant. Infectious virus was successfully isolated from 9 nasopharyngeal swabs, however only from one of the seven PCR positive ocular samples. We could detect SARS-CoV-2 in eyes of some of the infected patients albeit at lower levels compared to nasopharyngeal swabs. However, our results also indicate that lacrimal fluid might be infectious in patients with high viral load.

Identifiants

pubmed: 38500504
doi: 10.3389/fcimb.2024.1332157
pmc: PMC10946250
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1332157

Informations de copyright

Copyright © 2024 Kimpel, Rössler, Bante, Borena, von Laer, Zehetner, Rauchegger, Seiwald and Falkensammer.

Déclaration de conflit d'intérêts

DB declares to hold stocks of Pfizer and Oxford Nanopore Technologies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Janine Kimpel (J)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Annika Rössler (A)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

David Bante (D)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Wegene Borena (W)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Dorothee von Laer (D)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Claus Zehetner (C)

Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria.

Teresa Rauchegger (T)

Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria.

Stefanie Seiwald (S)

Department of Internal Medicine III, Medical University of Innsbruck, Innsbruck, Austria.

Barbara Falkensammer (B)

Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Classifications MeSH